CSF3R and chronic neutrophilic leukemia: The WHO once recommended that all suspected cases of CNL be screened for plasma cell disorders28 and that if present, neutrophil clonality be demonstrated via cytogenetic or molecular techniques in order for the hypothesis of CNL to be viable; however, with the current availability of the sensitive and specific CSF3R marker, as will be discussed, this is no longer required.